Insomnia Market Report by Therapy Type (Non-Pharmacological Therapy, Pharmacological Therapy), Drug Class (Antidepressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), and Region 2024-2032

Insomnia Market Report by Therapy Type (Non-Pharmacological Therapy, Pharmacological Therapy), Drug Class (Antidepressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A6148
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Insomnia Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Therapy Type
    6.1    Non-Pharmacological Therapy
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Hypnotherapy
           6.1.2.2 Cognitive Behavioral Therapy
           6.1.2.3 Medical Devices
           6.1.2.4 Others
        6.1.3 Market Forecast
    6.2    Pharmacological Therapy
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Prescription Sleep Aids
           6.2.2.2 Over-The-Counter Sleep Aids
        6.2.3 Market Forecast
7   Market Breakup by Drug Class
    7.1    Antidepressants
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Melatonin Antagonist
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Benzodiazepines
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Nonbenzodiazepines
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Orexin Antagonist
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Hospital Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Drug Stores
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Online Pharmacies
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Astellas Pharma Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Aurobindo Pharma Limited
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
        14.3.3    Biocodex
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Eisai Co. Ltd.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Mallinckrodt Pharmaceuticals
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
        14.3.6    Merck & Co. Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Neurim Pharmaceuticals Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Pfizer Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Sanofi S.A.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.)
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Takeda Pharmaceutical Company Limited
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Vanda Pharmaceuticals Inc.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
           14.3.12.3 Financials

List of Figures

Figure 1: Global: Insomnia Market: Major Drivers and Challenges
Figure 2: Global: Insomnia Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Insomnia Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Insomnia Market: Breakup by Therapy Type (in %), 2023
Figure 5: Global: Insomnia Market: Breakup by Drug Class (in %), 2023
Figure 6: Global: Insomnia Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Insomnia Market: Breakup by Region (in %), 2023
Figure 8: Global: Insomnia (Non-Pharmacological Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Insomnia (Non-Pharmacological Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Insomnia (Pharmacological Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Insomnia (Pharmacological Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Insomnia (Antidepressants) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Insomnia (Antidepressants) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Insomnia (Melatonin Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Insomnia (Melatonin Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Insomnia (Benzodiazepines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Insomnia (Benzodiazepines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Insomnia (Nonbenzodiazepines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Insomnia (Nonbenzodiazepines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Insomnia (Orexin Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Insomnia (Orexin Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Insomnia (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Insomnia (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Insomnia (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Insomnia (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Insomnia (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Insomnia (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Insomnia (Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Insomnia (Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Insomnia (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Insomnia (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: North America: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: North America: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: United States: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: United States: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Canada: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Canada: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Asia-Pacific: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Asia-Pacific: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: China: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: China: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Japan: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Japan: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: India: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: India: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: South Korea: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: South Korea: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Australia: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Australia: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Indonesia: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Indonesia: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Others: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Europe: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Europe: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Germany: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Germany: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: France: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: France: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: United Kingdom: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: United Kingdom: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Italy: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Italy: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Spain: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Spain: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Russia: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Russia: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Latin America: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Latin America: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Brazil: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Brazil: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Mexico: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Mexico: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Middle East and Africa: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Middle East and Africa: Insomnia Market: Breakup by Country (in %), 2023
Figure 80: Middle East and Africa: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Global: Insomnia Industry: SWOT Analysis
Figure 82: Global: Insomnia Industry: Value Chain Analysis
Figure 83: Global: Insomnia Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Insomnia Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Insomnia Market Forecast: Breakup by Therapy Type (in Million US$), 2024-2032
Table 3: Global: Insomnia Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 4: Global: Insomnia Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Insomnia Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Insomnia Market: Competitive Structure
Table 7: Global: Insomnia Market: Key Players

Insomnia Market Report by Therapy Type (Non-Pharmacological Therapy, Pharmacological Therapy), Drug Class (Antidepressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More